GlobeStar Therapeutics Corporation
GSTC
Rank in Stocks
#34366
GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm... GlobeStar Therapeutics Corporation is a clinical-stage biopharmaceutical firm dedicated to advancing proprietary drug formulations. These innovative treatments specifically target multiple sclerosis (MS) and various other neurodegenerative disorders. Established in 2016, the company was formerly known as AngioSoma, Inc., rebranding to GlobeStar Therapeutics Corporation in July 2021. Its operations are headquartered in Richland, Washington.
Share Price
$0.00001
Last synced: 2026-11-17
Market Cap
$12.09K
Change (1 day)
-90.00%
Change (1 year)
-90.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade GlobeStar Therapeutics Corporation (GSTC)
Category
Healthcare
EPS for GlobeStar Therapeutics Corporation (GSTC)
EPS as of June 2024 TTM: $0.00
According to GlobeStar Therapeutics Corporation's latest financial reports, its current EPS (TTM) is $0.00. At the end of 2023 the company had an EPS of 0.00, equal to its 2022 EPS of 0.00.
EPS history for GlobeStar Therapeutics Corporation from 2010 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | 0.00 | 0.00% |
| 2023 | 0.00 | 0.00% |
| 2022 | 0.00 | -88.18% |
| 2021 | $-0.02 | 1,027.78% |
| 2020 | 0.00 | -82.00% |
| 2019 | $-0.01 | -31.03% |
| 2018 | $-0.01 | -66.36% |
| 2017 | $-0.04 | -64.08% |
| 2016 | $-0.12 | -81.82% |
| 2015 | $-0.66 | -91.20% |
| 2014 | $-7.50 | -37.50% |
| 2013 | $-12.00 | -89.69% |
| 2012 | $-116.38 | 1,013.68% |
| 2011 | $-10.45 | 2,171.74% |
| 2010 | $-0.46 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -1,566,100.00% |
US
|
|
| $-7.07 | 706,900.00% |
US
|
|
| $-5.29 | 528,900.00% |
AU
|
|
| $12.73 | -1,273,320.00% |
BE
|
|
| $21.56 | -2,156,100.00% |
NL
|
Questions about GlobeStar Therapeutics Corporation's earnings per share (EPS)
What is GlobeStar Therapeutics Corporation's earnings per share (EPS)?
GlobeStar Therapeutics Corporation's earnings per share (EPS) over the last twelve months is $0.00, as of Jun 2024.
What was GlobeStar Therapeutics Corporation's earnings per share (EPS) in 2023?
In 2023, GlobeStar Therapeutics Corporation's earnings per share (EPS) was 0.00, compared with 0.00 in 2022.
How has GlobeStar Therapeutics Corporation's earnings per share (EPS) changed since 2018?
From 2018 to 2023, GlobeStar Therapeutics Corporation's earnings per share (EPS) was highest in 2023 (0.00) and lowest in 2021 ($-0.02).
How does GlobeStar Therapeutics Corporation's earnings per share (EPS) compare with similar companies?
GlobeStar Therapeutics Corporation's earnings per share (EPS) ($0.00) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.